Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies
Mingtao Liu, Hui Gan, Zhiman Liang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 11

Showing 11 citing articles:

SARS-CoV-2 Specific Nanobodies Neutralize Different Variants of Concern and Reduce Virus Load in the Brain of h-ACE2 Transgenic Mice
María F. Pavan, Marina Bok, Rafael Betanzos San Juan, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 185-185
Open Access | Times Cited: 3
Development of potent pan‐coronavirus fusion inhibitors with a new design strategy
Yuanmei Zhu, Zhongcai Gao, Xiaoli Feng, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 3
The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
Binbin Xia, Zheng Li, Yali Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
A Multi-Faceted Binding Assessment of Aptamers Targeting the SARS-CoV-2 Spike Protein
Laia Civit, Nima Moradzadeh, Anna Jończyk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4642-4642
Open Access | Times Cited: 1
In vitro generated antibodies guide thermostable ADDomer nanoparticle design for nasal vaccination and passive immunization against SARS-CoV-2
Dora Buzas, Adrian H Bunzel, Oskar Staufer, et al.
Antibody Therapeutics (2023) Vol. 6, Iss. 4, pp. 277-297
Open Access | Times Cited: 2
Navigating Immune Landscapes: Insights From A Prospective Study
Izzatul Aliaa Badaruddin, Zulhabri Othman, Wan Muhammad Azfar Wan Shuaib, et al.
Asia Pacific Journal of Public Health (2024)
Closed Access
Functional Activity and Binding Specificity of small Ankyron Repeat Proteins against SARS-CoV-2 variants
Y.K. Park, Wojciech Jankowski, Nicholas C Hurst, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
AI Promoted Virtual Screening, Structure-Based Hit Optimization, and Synthesis of Novel COVID-19 S-RBD Domain Inhibitors
Ioannis Gkekas, Sotirios Katsamakas, Stelios K. Mylonas, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 22, pp. 8562-8585
Open Access
Clinical and laboratory considerations: Determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19
Stefan Holdenrieder, Carlos Eduardo dos Santos Ferreira, Jacques Izopet, et al.
Authorea (Authorea) (2023)
Open Access
Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea
Ji Yeon Lee, Seon Hee Bu, Eun-Hyang Song, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 10, pp. 2417-2435
Open Access
Clinical and laboratory considerations: determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19
Stefan Holdenrieder, Carlos Eduardo dos Santos Ferreira, Jacques Izopet, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access
Page 1

Scroll to top